Clinical outcome of hepatocellular carcinoma can be predicted by the expression of hepatic progenitor cell markers and serum tumour markers

The high heterogeneity of hepatocellular carcinomas (HCCs) complicates stratification of HCC patients for treatment. Therefore, it is necessary to establish a comprehensive panel of HCC biomarkers related to tumour behaviour and cancer prognosis. Resected HCCs from 251 patients were stained for hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Seino, Satoshi, Tsuchiya, Atsunori, Watanabe, Yusuke, Kawata, Yuzo, Kojima, Yuichi, Ikarashi, Shunzo, Yanai, Hiroyuki, Nakamura, Koji, Kumaki, Daisuke, Hirano, Masaaki, Funakoshi, Kazuhiro, Aono, Takashi, Sakai, Takeshi, Sakata, Jun, Takamura, Masaaki, Kawai, Hirokazu, Yamagiwa, Satoshi, Wakai, Toshifumi, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955154/
https://www.ncbi.nlm.nih.gov/pubmed/29774107
http://dx.doi.org/10.18632/oncotarget.25074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955154/
https://www.ncbi.nlm.nih.gov/pubmed/29774107
http://dx.doi.org/10.18632/oncotarget.25074

Ejemplares similares